Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

× No keyword cloud information.

51 in total

1. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.

Authors: F J Crosson; J A Winkelstein; E R Moxon
Journal: Infect Immun Date: 1976-10 Impact factor: 3.441

2. [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors: D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal: Klin Wochenschr Date: 1975-08-15

3. Immunologic defense in bacterial and viral meningitis in children.

Authors: J Ströder; R Seger
Journal: Eur J Pediatr Date: 1976-12-09 Impact factor: 3.183

4. Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.

Authors: A J Turley; B Gathmann; C Bangs; M Bradbury; S Seneviratne; L I Gonzalez-Granado; S Hackett; N Kutukculer; H Alachkar; S Hambleton; H Ritterbusch; P Kralickova; L Marodi; M G Seidel; G Dueckers; J Roesler; A Huissoon; H Baxendale; J Litzman; P D Arkwright
Journal: J Clin Immunol Date: 2015-02-08 Impact factor: 8.317

9. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

Authors: B H Petersen; J A Graham; G F Brooks
Journal: J Clin Invest Date: 1976-02 Impact factor: 14.808

10. A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.

Authors: B Wellek; W Opferkuch
Journal: Clin Exp Immunol Date: 1975-02 Impact factor: 4.330

A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

1. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.

2. [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

3. Immunologic defense in bacterial and viral meningitis in children.

4. Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.

5. Yeast opsonization in newborn infants and its relationship to parental atopy.

6. The role of complement and antibody in opsonization and intracellular killing of Candida albicans.

7. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.

8. Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.

9. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

10. A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.